Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Social Media Could Improve Compliance, Enforcement Transparency, FDA Says

This article was originally published in The Pink Sheet Daily

Executive Summary

FDA report on increasing public access to compliance and enforcement data recommends that the agency deploy new electronic tools and assess stakeholder need for mobile Web applications.

You may also be interested in...



Industry Compliance Data Should Be Linked To Enforcement Results, FDA Transparency Taskforce Says

FDA's website should resemble EPA's and Department of Labor's, report concludes.

Where's Your Application? FDA May Soon Have An App For That

Agency's transparency initiative may include a tracking system similar to Health Canada's so that reviewers can avoid having to field phone calls from sponsors asking about the status of an application.

Companies Reveal Hurdles In Providing Drugs Via Expanded Access Programs

GSK, Stealth BioTherapeutics and Blueprint Medicines discuss the difficulties getting participation of physicians, the excessive cost of expanded access, and whether physicians should report research data.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS077135

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel